Semler Scientific (Nasdaq:SMLR) - Aandelenkoers, Nieuws & Analyse

SMLR Overzicht aandelen

Semler Scientific, Inc. biedt technologische oplossingen om de klinische effectiviteit en efficiëntie van zorgverleners in de Verenigde Staten te verbeteren.

Over het bedrijf

SMLR fundamentele analyse
Sneeuwvlok Score
Waardering	4/6
Toekomstige groei	0/6
Prestaties in het verleden	2/6
Financiële gezondheid	6/6
Dividenden	0/6

Beloningen

Trading at 45.8% below our estimate of its fair value

Risicoanalyse

High level of non-cash earnings

Significant insider selling over the past 3 months

Semler Scientific, Inc. Concurrenten

Electromed

NYSEAM:ELMD

US$192.5m

Zynex

NasdaqGS:ZYXI

US$279.0m

Tactile Systems Technology

NasdaqGM:TCMD

US$352.1m

Jin Medical International

NasdaqCM:ZJYL

US$320.9m

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Semler Scientific
Historische aandelenkoersen
Huidige aandelenkoers	US$30.68
52 Week Hoogtepunt	US$53.38
52 Week Laag	US$20.88
Bèta	0.96
11 maand verandering	22.77%
3 maanden verandering	11.48%
1 Jaar Verandering	4.25%
33 jaar verandering	-72.83%
5 jaar verandering	-32.57%
Verandering sinds IPO	338.91%

Recent nieuws en updates

Semler Scientific, Inc. (NASDAQ:SMLR) Held Back By Insufficient Growth Even After Shares Climb 27%

Nov 02

Recent updates

Semler Scientific, Inc. (NASDAQ:SMLR) Held Back By Insufficient Growth Even After Shares Climb 27%

Nov 02

Earnings Troubles May Signal Larger Issues for Semler Scientific (NASDAQ:SMLR) Shareholders

Aug 14

The Market Doesn't Like What It Sees From Semler Scientific, Inc.'s (NASDAQ:SMLR) Earnings Yet

Jul 18

We Ran A Stock Scan For Earnings Growth And Semler Scientific (NASDAQ:SMLR) Passed With Ease

May 08

Things Look Grim For Semler Scientific, Inc. (NASDAQ:SMLR) After Today's Downgrade

Mar 08

Semler Scientific: Why I'm Buying

Mar 05

Should You Investigate Semler Scientific, Inc. (NASDAQ:SMLR) At US$52.64?

Mar 02

Semler's Unique Business Model Is Fueling Profitable Growth

Feb 23

Better Price For Semler Is Likely

Jan 05

Semler Scientific's (NASDAQ:SMLR) Earnings Are Weaker Than They Seem

Nov 12

It Looks Like The CEO Of Semler Scientific, Inc. (NASDAQ:SMLR) May Be Underpaid Compared To Peers

Oct 15

Semler Scientific: Rapidly Growing Medical Device Company

Oct 14

There's Reason For Concern Over Semler Scientific, Inc.'s (NASDAQ:SMLR) Massive 28% Price Jump

Oct 14

Rendement voor aandeelhouders

	SMLR	US Medical Equipment	US Markt
7D	3.8%	0.2%	-1.6%
1Y	4.2%	25.8%	30.8%

Rendement versus industrie: SMLR underperformed the US Medical Equipment industry which returned 25.8% over the past year.

Rendement versus markt: SMLR underperformed the US Market which returned 30.8% over the past year.

Prijsvolatiliteit

Is SMLR's price volatile compared to industry and market?
SMLR volatility
SMLR Average Weekly Movement	8.6%
Medical Equipment Industry Average Movement	8.0%
Market Average Movement	6.0%
10% most volatile stocks in US Market	14.9%
10% least volatile stocks in US Market	2.9%

Stabiele aandelenkoers: SMLR has not had significant price volatility in the past 3 months compared to the US market.

Volatiliteit in de loop van de tijd: SMLR's weekly volatility (9%) has been stable over the past year.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
2007	92	Doug Murphy-Chutorian	www.semlerscientific.com

Semler Scientific, Inc. biedt technologische oplossingen om de klinische effectiviteit en efficiëntie van zorgverleners in de Verenigde Staten te verbeteren. De producten van het bedrijf omvatten QuantaFlo, een vier minuten durende bloeddoorstromingstest waarmee zorgverleners de bloeddoorstroming kunnen meten als onderdeel van hun onderzoek naar de vasculaire conditie van een patiënt. Het bedrijf biedt ook Insulin Insights, een softwareprogramma dat door zorgverleners wordt gebruikt om de ambulante insulinedosering te optimaliseren.

Semler Scientific, Inc. Samenvatting

Hoe verhouden de winst en inkomsten van Semler Scientific zich tot de beurswaarde?
SMLR fundamentele statistieken
Marktkapitalisatie	US$214.52m
Inkomsten(TTM)	US$15.82m
Inkomsten(TTM)	US$61.74m

13.6x

Koers/Winstverhouding

3.5x

P/S-verhouding

Is SMLR overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
SMLR resultatenrekening (TTM)
Inkomsten	US$61.74m
Kosten van inkomsten	US$7.00m
Brutowinst	US$54.74m
Overige uitgaven	US$38.93m
Inkomsten	US$15.82m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

Nov 04, 2024

Winst per aandeel (EPS)	2.26
Brutomarge	88.67%
Nettowinstmarge	25.62%
Schuld/Eigen Vermogen Verhouding	0%

Hoe presteerde SMLR op de lange termijn?

Bekijk historische prestaties en vergelijking

SMLR Overzicht aandelen

Beloningen

Risicoanalyse

Semler Scientific, Inc. Concurrenten

NYSEAM:ELMD

US$192.5m

NasdaqGS:ZYXI

US$279.0m

NasdaqGM:TCMD

US$352.1m

NasdaqCM:ZJYL

US$320.9m

Prijsgeschiedenis en prestaties

Recent nieuws en updates

Semler Scientific, Inc. (NASDAQ:SMLR) Held Back By Insufficient Growth Even After Shares Climb 27%

Investor sentiment improves as stock rises 22%

Semler Scientific, Inc. to Report Q3, 2024 Results on Nov 04, 2024

CEO, President & Director recently sold US$306k worth of stock

CEO, President & Director exercised options to buy US$2.0m worth of stock.

Semler Scientific, Inc., Annual General Meeting, Oct 04, 2024

Recent updates

Semler Scientific, Inc. (NASDAQ:SMLR) Held Back By Insufficient Growth Even After Shares Climb 27%

Investor sentiment improves as stock rises 22%

Semler Scientific, Inc. to Report Q3, 2024 Results on Nov 04, 2024

CEO, President & Director recently sold US$306k worth of stock

CEO, President & Director exercised options to buy US$2.0m worth of stock.

Semler Scientific, Inc., Annual General Meeting, Oct 04, 2024

Earnings Troubles May Signal Larger Issues for Semler Scientific (NASDAQ:SMLR) Shareholders

New minor risk - Shareholder dilution

Second quarter 2024 earnings released: EPS: US$0.002 (vs US$0.88 in 2Q 2023)

New major risk - Share price stability

Investor sentiment deteriorates as stock falls 20%

Semler Scientific, Inc. to Report Q2, 2024 Results on Aug 05, 2024

The Market Doesn't Like What It Sees From Semler Scientific, Inc.'s (NASDAQ:SMLR) Earnings Yet

Semler Scientific, Inc. has filed a Follow-on Equity Offering in the amount of $50 million.

Investor sentiment improves as stock rises 36%

Investor sentiment improves as stock rises 38%

Investor sentiment deteriorates as stock falls 17%

New minor risk - Shareholder dilution

Price target decreased by 38% to US$40.00

First quarter 2024 earnings: EPS and revenues miss analyst expectations

We Ran A Stock Scan For Earnings Growth And Semler Scientific (NASDAQ:SMLR) Passed With Ease

Semler Scientific, Inc. to Report Q1, 2024 Results on May 07, 2024

Many Still Looking Away From Semler Scientific, Inc. (NASDAQ:SMLR)

New minor risk - Shareholder dilution

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment deteriorates as stock falls 18%

Now 25% undervalued after recent price drop

Semler Scientific, Inc. to Report Q4, 2023 Results on Mar 05, 2024

Is Now The Time To Put Semler Scientific (NASDAQ:SMLR) On Your Watchlist?

Investor sentiment improves as stock rises 16%

Estimating The Intrinsic Value Of Semler Scientific, Inc. (NASDAQ:SMLR)

Investor sentiment improves as stock rises 33%

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

New minor risk - Shareholder dilution

Semler Scientific, Inc. to Report Q3, 2023 Results on Nov 09, 2023

Semler Scientific, Inc. Announces Steps Down of Abbie" Leibowitz as Class II Director

Investor sentiment improves as stock rises 15%

Semler Scientific, Inc., Annual General Meeting, Oct 19, 2023

Semler Scientific, Inc. to Report Q2, 2023 Results on Aug 10, 2023

Investor sentiment improves as stock rises 24%

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

What Does Semler Scientific, Inc.'s (NASDAQ:SMLR) Share Price Indicate?

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Now 26% undervalued after recent price drop

Investor sentiment improves as stock rises 15%

Semler Scientific, Inc. Announces Major Clinical Study Using Semler's QuantaFlo® for Medicare Advantage Beneficiaries, Demonstrates that National, In-Home Screening for Peripheral Artery Disease (PAD) is Feasible

Investor sentiment improved over the past week

Calculating The Intrinsic Value Of Semler Scientific, Inc. (NASDAQ:SMLR)

Price target decreased to US$55.00

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Semler Scientific Updates Financial Guidance for the Year Ending December 31, 2022

Semler Scientific, Inc. to Report Q3, 2022 Results on Nov 01, 2022

Semler Scientific, Inc., Annual General Meeting, Oct 20, 2022

Semler Scientific, Inc. Provides Earnings Guidance for Second Half and Full Year Ended December 31, 2022

Second quarter 2022 earnings: EPS exceeds analyst expectations

Semler Scientific, Inc. Provides Earnings Guidance for Second Half and Full Year Ended December 31, 2022

Semler Scientific: Growth, Profits, And Valuation Models Support A Buy

Investor sentiment improved over the past week

Semler Scientific, Inc. to Report Q2, 2022 Results on Aug 02, 2022